로딩 중…
지수 로딩 중…
Verastem, Inc.
VSTM· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$4.12-1.20%
2026-06-18
Price Chart
Verastem, Inc.-20.62%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $362M |
| Revenue | $50M |
| Net Income | $-194M |
| Total Assets | $228M |
| Net Assets | $82M |
| Value | |
| P/B | 4.43x |
| P/S | 7.30x |
| FCF Yield | -41.69% |
| Profitability | |
| ROA | -85.14% |
| Op. Margin | -344.56% |
| Revenue Growth | 209.14% |
| Financial Health | |
| Debt Ratio | 178.57% |
| Total Debt | $85M |
| FCF | $-151M |
| Cash | $166M |
| Current Ratio | 3.04x |
| Performance | |
| 1Y Return | -20.62% |
| 1M Return | -0.72% |
| From 52W High | -63.38% |
| 1Y MDD | -66.39% |
| Trading | |
| Volume | 3,842,438 shares |
| Trading Value | $16M |
| Per Share | |
| EPS | $-2.51 |
| BPS | $0.69 |